SCHEMBL7068565

SCHEMBL7068565

c1ccc(CC(c2nc3ccccc3[nH]2)N2CCC3CCCCC32)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
CYP1A2 P05177 1/20 0.42
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 1/20 0.42
GRIN2B Q13224 2/20 0.41
GRIN1 Q05586 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
LMNA P02545 1/20 0.40
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39
MAPK1 P28482 2/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
TP53 P04637 1/20 0.39
IDO1 P14902 1/20 0.39
POLB P06746 1/20 0.39
GRIN2A Q12879 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL377140 0.71 GAA (0.44) CYP3A4CYP2D6CYP2C9CYP2C19CYP1A2
SCHEMBL377139 0.71 GAA (0.44) CYP3A4CYP2D6CYP2C9CYP2C19CYP1A2
SCHEMBL14127791 0.68 DPP4 (0.43) CYP3A4CYP2D6CYP2C19CYP1A2GRIN2B
SCHEMBL27756416 0.68 TAAR1 (0.63) CYP3A4CYP2D6CYP2C9CYP2C19CYP1A2
SCHEMBL25638545 0.68 TAAR1 (0.55) CYP3A4CYP2D6CYP2C9CYP2C19CYP1A2
SCHEMBL630978 0.68 TAAR1 (0.63) CYP3A4CYP2D6CYP2C9CYP2C19CYP1A2
SCHEMBL6097414 0.68 AKR1C3 (0.44) CYP3A4CYP2D6CYP2C9CYP2C19ALDH1A1
SCHEMBL6093822 0.67 KMT2A (0.46) CYP3A4CYP2D6CYP2C9CYP2C19CYP1A2
SCHEMBL6095523 0.67 KMT2A (0.46) CYP3A4CYP2D6CYP2C9CYP2C19CYP1A2
SCHEMBL13356551 0.66 HTT (0.57) GRIN2BGRIN1LMNAGAAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242074-A4 5-BENZYL-OCTAHYDROINDOLE AND 6-BENZYL-DECAHYDROQUINOLINE NMDA/NR2B ANTAGONISTS MERCK & CO INC (US) 2003-01-29 EP claimed
EP-1242074-A1 5-BENZYL-OCTAHYDROINDOLE AND 6-BENZYL-DECAHYDROQUINOLINE NMDA/NR2B ANTAGONISTS Merck & Co., Inc. (US) 2002-09-25 EP claimed
US-6369076-B1 ANALGESICS MERCK & CO. INC. 2002-04-09 US claimed
WO-2001032171-A1 5-BENZYL-OCTAHYDROINDOLE AND 6-BENZYL-DECAHYDROQUINOLINE NMDA/NR2B ANTAGONISTS MERCK & CO., INC. (US) 2001-05-10 WO claimed
EP-1242074-A4 5-BENZYL-OCTAHYDROINDOLE AND 6-BENZYL-DECAHYDROQUINOLINE NMDA/NR2B ANTAGONISTS MERCK & CO INC (US) 2003-01-29 EP disclosed
EP-1242074-A1 5-BENZYL-OCTAHYDROINDOLE AND 6-BENZYL-DECAHYDROQUINOLINE NMDA/NR2B ANTAGONISTS Merck & Co., Inc. (US) 2002-09-25 EP disclosed
US-6369076-B1 ANALGESICS MERCK & CO. INC. 2002-04-09 US disclosed
WO-2001032171-A1 5-BENZYL-OCTAHYDROINDOLE AND 6-BENZYL-DECAHYDROQUINOLINE NMDA/NR2B ANTAGONISTS MERCK & CO., INC. (US) 2001-05-10 WO disclosed